Discover more insights into Human Programmed 人类编程

Keywords frequently search together with Human Programmed 人类编程

Narrow sentence examples with built-in keyword filters

Human Programmed sentence examples within death ligand 1



A size-shrinkable matrix metallopeptidase-2-sensitive delivery nanosystem improves the penetration of human programmed death-ligand 1 siRNA into lung-tumor spheroids


Construction of PD-L1-siRNA and IL-2 DNA loading PEI lipid nanoparticles in activating T cells and treating lung cancer

Human Programmed sentence examples within cell death 1



Mapping the Binding Hot Spots on Human Programmed Cell Death 1 and Its Ligand with Free-Energy Simulations


Perforation of small intestinal metastasis of lung adenocarcinoma treated with pembrolizumab: a case report

Human Programmed sentence examples within human programmed death



A size-shrinkable matrix metallopeptidase-2-sensitive delivery nanosystem improves the penetration of human programmed death-ligand 1 siRNA into lung-tumor spheroids


SCREENING OF SOME SELECTED COMPOUNDS IN ROSELLA (Hibiscus sabdariffa L.) TARGETING OF COMPLEX HUMAN PROGRAMMED DEATH-1 AND ITS LIGAND-1 (hPD1/PD-L1) AS IMUNOMODULATORY ACTIVITY: In silico APPROACH


Learn more from Human Programmed 人类编程


Human Programmed sentence examples within human programmed cell



Penpulimab in combination with anlotinib as first-line treatment in advanced nonsquamous non-small-cell lung cancer.


Mapping the Binding Hot Spots on Human Programmed Cell Death 1 and Its Ligand with Free-Energy Simulations

More Human Programmed 人类编程 sentence examples
10.1200/JCO.2021.39.15_SUPPL.E21072

Penpulimab in combination with anlotinib as first-line treatment in advanced nonsquamous non-small-cell lung cancer.



A size-shrinkable matrix metallopeptidase-2-sensitive delivery nanosystem improves the penetration of human programmed death-ligand 1 siRNA into lung-tumor spheroids



SCREENING OF SOME SELECTED COMPOUNDS IN ROSELLA (Hibiscus sabdariffa L.) TARGETING OF COMPLEX HUMAN PROGRAMMED DEATH-1 AND ITS LIGAND-1 (hPD1/PD-L1) AS IMUNOMODULATORY ACTIVITY: In silico APPROACH



Construction of PD-L1-siRNA and IL-2 DNA loading PEI lipid nanoparticles in activating T cells and treating lung cancer



JUPITOR-02: Randomized, Double-Blind, Phase 3 Study of Toripalimab or Placebo Plus Cisplatin and Gemcitabine as First-Line Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma



A phase II study of sintilimab plus anlotinib for Chinese patients (pts) with persistent, recurrent or metastatic cervical cancer (CC)



Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial.



Abstract CT227: A phase 1 multiple ascending dose study to investigate the safety, pharmacokinetics, pharmacodynamics and preliminary efficacy of KD033 in subjects with metastatic or locally advanced solid tumors



Abstract 1155: Subcutaneous intratumoral administration of a novel oncolytic virus leads to eradication of peritoneal disseminated pancreatic cancer in nude mice



Pharmacokinetics, Pharmacodynamics, and Safety of Nivolumab in Patients With Sepsis-Induced Immunosuppression: A Multicenter, Open-Label Phase 1/2 Study



Nivolumab-induced adrenalitis



Mapping the Binding Hot Spots on Human Programmed Cell Death 1 and Its Ligand with Free-Energy Simulations



Perforation of small intestinal metastasis of lung adenocarcinoma treated with pembrolizumab: a case report



Programmed cell death 1 gene polymorphism as a possible risk for systemic lupus erythematosus in Egyptian females



A small-sized protein binder specific for human PD-1 effectively suppresses the tumour growth in tumour mouse model



Enhanced Therapeutic Efficacy of a Novel Oncolytic Herpes Simplex Virus Type 2 Encoding an Antibody Against Programmed Cell Death 1



High-affinity human programmed death-1 ligand-1 variant promotes redirected T cells to kill tumor cells.



MiRNA-182 regulates the cardiomyocyte apoptosis in heart failure.



Interferon-γ upregulates Δ42PD1 expression on human monocytes via the PI3K/AKT pathway.


Learn more from Human Programmed 人类编程

Human Programmed 人类编程


Human Programmed 人类编程
Encyclopedia 百科全书